MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BIIB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Biogen (BIIB) Earnings Date & Reports

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

BIIB is expected to report earnings to rise 52.76% to $3.04 per share on April 29

Biogen BIIB Stock Earnings Reports
Q1'26
Est.
$3.04
Q4'25
Beat
by $0.38
Q3'25
Beat
by $0.93
Q2'25
Beat
by $1.48
Q1'25
Beat
by $0.06
The last earnings report on February 06 showed earnings per share of $1.99, beating the estimate of $1.61. With 1.24M shares outstanding, the current market capitalization sits at 26.03B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BIIB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BIIB showed earnings on February 06, 2026. You can read more about the earnings report here.
View AI-Driven Trading for BIIB
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com